Skip to main content
. 2020 Apr 17;12(4):1128. doi: 10.3390/nu12041128

Figure 3.

Figure 3

Change from baseline in serum zinc concentrations (µg/dL) (by dose of polaprezinc vs. placebo for the primary analysis population, patients with serum zinc concentrations of less than 70 µg/dL).